Variant report
Variant | nsv525415 |
---|---|
Chromosome Location | chr7:11791621-11795598 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:52)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr7:11793826-11794047 | GM12878 | blood: | n/a | n/a |
2 | BCL3 | chr7:11790859-11792070 | A549 | lung: | n/a | n/a |
3 | BCL3 | chr7:11791136-11792059 | A549 | lung: | n/a | n/a |
4 | CREB1 | chr7:11791682-11791955 | A549 | lung: | n/a | n/a |
5 | CTCF | chr7:11794706-11794776 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CTCF | chr7:11794660-11794810 | A549 | lung: | n/a | n/a |
7 | CTCF | chr7:11794679-11794826 | A549 | lung: | n/a | n/a |
8 | CTCF | chr7:11794700-11794850 | BE2_C | brain: | n/a | n/a |
9 | CTCF | chr7:11794680-11794830 | HepG2 | liver: | n/a | n/a |
10 | EP300 | chr7:11793944-11793993 | GM12878 | blood: | n/a | n/a |
11 | EP300 | chr7:11793880-11794080 | GM12878 | blood: | n/a | n/a |
12 | EP300 | chr7:11790865-11792180 | A549 | lung: | n/a | chr7:11791071-11791085 |
13 | EP300 | chr7:11793906-11794070 | GM12878 | blood: | n/a | n/a |
14 | EP300 | chr7:11790460-11792207 | A549 | lung: | n/a | chr7:11791071-11791085 |
15 | FOSL2 | chr7:11790835-11791966 | A549 | lung: | n/a | chr7:11791126-11791134 |
16 | FOXA1 | chr7:11791555-11791984 | T-47D | breast: | n/a | n/a |
17 | FOXA1 | chr7:11791597-11791897 | T-47D | breast: | n/a | n/a |
18 | FOXA2 | chr7:11791223-11792188 | A549 | lung: | n/a | n/a |
19 | FOXA2 | chr7:11791403-11792120 | A549 | lung: | n/a | n/a |
20 | GATA3 | chr7:11791540-11792063 | MCF-7 | breast: | n/a | n/a |
21 | GATA3 | chr7:11790958-11792108 | A549 | lung: | n/a | n/a |
22 | GATA3 | chr7:11790758-11792156 | A549 | lung: | n/a | n/a |
23 | GATA3 | chr7:11791565-11791961 | T-47D | breast: | n/a | n/a |
24 | JUND | chr7:11791459-11792011 | A549 | lung: | n/a | n/a |
25 | MAX | chr7:11790782-11792116 | A549 | lung: | n/a | chr7:11791320-11791329 |
26 | MEF2A | chr7:11793703-11794160 | GM12878 | blood: | n/a | n/a |
27 | NFIC | chr7:11793666-11794141 | GM12878 | blood: | n/a | n/a |
28 | NR2F2 | chr7:11791525-11791935 | MCF-7 | breast: | n/a | n/a |
29 | NR2F2 | chr7:11791569-11792034 | MCF-7 | breast: | n/a | n/a |
30 | NR3C1 | chr7:11790859-11792173 | A549 | lung: | n/a | chr7:11791125-11791134 chr7:11791126-11791135 |
31 | NR3C1 | chr7:11791520-11791986 | A549 | lung: | n/a | n/a |
32 | NR3C1 | chr7:11791532-11792077 | A549 | lung: | n/a | n/a |
33 | NR3C1 | chr7:11791481-11792051 | A549 | lung: | n/a | n/a |
34 | NR3C1 | chr7:11791632-11791962 | A549 | lung: | n/a | n/a |
35 | NR3C1 | chr7:11791436-11792077 | A549 | lung: | n/a | n/a |
36 | NR3C1 | chr7:11791503-11792026 | A549 | lung: | n/a | n/a |
37 | POLR2A | chr7:11791387-11792058 | PANC-1 | pancreas: | n/a | n/a |
38 | POLR2A | chr7:11791437-11792012 | PANC-1 | pancreas: | n/a | n/a |
39 | POLR2A | chr7:11791812-11791923 | Gliobla | brain: | n/a | n/a |
40 | POLR2A | chr7:11791796-11791904 | A549 | lung: | n/a | n/a |
41 | POLR2A | chr7:11791786-11791811 | Gliobla | brain: | n/a | n/a |
42 | REST | chr7:11790973-11792042 | A549 | lung: | n/a | n/a |
43 | RUNX3 | chr7:11793805-11794135 | GM12878 | blood: | n/a | n/a |
44 | RUNX3 | chr7:11793799-11794069 | GM12878 | blood: | n/a | n/a |
45 | SP1 | chr7:11790800-11792218 | A549 | lung: | n/a | chr7:11791034-11791046 chr7:11791034-11791046 |
46 | SP1 | chr7:11790901-11792119 | A549 | lung: | n/a | chr7:11791034-11791046 chr7:11791034-11791046 |
47 | SPI1 | chr7:11793799-11794027 | GM12891 | blood: | n/a | chr7:11793907-11793916 |
48 | TCF12 | chr7:11791375-11791958 | A549 | lung: | n/a | chr7:11791736-11791743 |
49 | TCF12 | chr7:11790726-11792272 | A549 | lung: | n/a | chr7:11791736-11791743 |
50 | TCF7L2 | chr7:11791026-11792212 | PANC-1 | pancreas: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
THSD7A | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10950366 | chr7:11791621-11791622 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs535608562 | chr7:11791622-11791623 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs560832709 | chr7:11791623-11791624 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs555718171 | chr7:11791626-11791627 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs188433976 | chr7:11791652-11791653 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs546239611 | chr7:11791654-11791655 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs192856677 | chr7:11791678-11791679 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs113318163 | chr7:11791743-11791744 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs560972480 | chr7:11791753-11791754 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs147572068 | chr7:11791757-11791758 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs546611902 | chr7:11791762-11791763 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs566406555 | chr7:11791767-11791768 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs10499405 | chr7:11791774-11791775 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs373298222 | chr7:11791786-11791787 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs568474937 | chr7:11791787-11791788 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs373696206 | chr7:11791788-11791789 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs10499404 | chr7:11791832-11791833 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs554648659 | chr7:11791833-11791834 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs574976236 | chr7:11791849-11791850 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs186625742 | chr7:11791850-11791851 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs62433410 | chr7:11791873-11791874 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs79873245 | chr7:11791891-11791892 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs28712322 | chr7:11791974-11791975 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs191575796 | chr7:11791988-11791989 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs562871889 | chr7:11792059-11792060 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs115498178 | chr7:11792063-11792064 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs577913490 | chr7:11792079-11792080 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs541999520 | chr7:11792125-11792126 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs184897179 | chr7:11792188-11792189 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs529874435 | chr7:11792197-11792198 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs546793587 | chr7:11792250-11792251 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs199626945 | chr7:11792295-11792296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111967214 | chr7:11792317-11792318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4721010 | chr7:11792368-11792369 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs552006812 | chr7:11792369-11792370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117711443 | chr7:11792372-11792373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190740840 | chr7:11792391-11792392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548016847 | chr7:11792395-11792396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568129003 | chr7:11792397-11792398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115466537 | chr7:11792463-11792464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554413959 | chr7:11792476-11792477 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181682148 | chr7:11792479-11792480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540180376 | chr7:11792491-11792492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112229481 | chr7:11792525-11792526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185154660 | chr7:11792532-11792533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574198635 | chr7:11792540-11792541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142076445 | chr7:11792557-11792558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561904780 | chr7:11792568-11792569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572520095 | chr7:11792579-11792580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs59311662 | chr7:11792580-11792581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Rett syndrome | 21593744 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:11783000-11793000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr7:11790400-11791800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr7:11790600-11792600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr7:11791600-11791800 | Active TSS | A549 | lung |
5 | chr7:11791600-11792000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr7:11791600-11792200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr7:11791600-11795000 | Weak transcription | Placenta | Placenta |
8 | chr7:11791800-11792000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr7:11791800-11792000 | Flanking Active TSS | A549 | lung |
10 | chr7:11792000-11792200 | Enhancers | A549 | lung |
11 | chr7:11792000-11793000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr7:11792200-11792400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr7:11792200-11792600 | Weak transcription | A549 | lung |
14 | chr7:11792600-11795000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr7:11792600-11795000 | Enhancers | A549 | lung |
16 | chr7:11792800-11793400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr7:11792800-11794200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
18 | chr7:11793000-11793400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr7:11793000-11793400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr7:11793000-11793400 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr7:11794200-11794800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
22 | chr7:11794800-11796400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
23 | chr7:11795000-11795400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
24 | chr7:11795000-11795400 | Enhancers | Placenta | Placenta |
25 | chr7:11795000-11795400 | Flanking Active TSS | A549 | lung |
26 | chr7:11795400-11795600 | Active TSS | A549 | lung |
27 | chr7:11795400-11798000 | Weak transcription | Placenta | Placenta |